
TPI is focused on developing, producing and marketing implantable "state of the art" products made of human bone for orthopaedic and dental use.
TPI is a business unit of
aap Implantate AG.
TPI obtained a bone bank licence from the Dutch health care authorities, the basis for being active in this medical field. The European directive (2004/23/EG) setting standards of quality and safety for human tissues and cells is followed as well as the FDA guideline 21 CFR Part 1271 current good tissue practice.